Pancreatic Neoplasms  >>  alisertib (MLN8237)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
alisertib (MLN8237) / Puma
NCT01677559: Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies

Completed
1
34
US
MLN8237, nab-Paclitaxel, Abraxane, Coroxane, Capxol
Washington University School of Medicine
Adenocarcinoma, Pancreatic Neoplasms
09/14
08/17

Download Options